Small Molecule Optoacoustic Contrast Agents: An Unexplored Avenue for Enhancing In Vivo Imaging
- PMID: 30366395
- PMCID: PMC6278390
- DOI: 10.3390/molecules23112766
Small Molecule Optoacoustic Contrast Agents: An Unexplored Avenue for Enhancing In Vivo Imaging
Abstract
Almost every variety of medical imaging technique relies heavily on exogenous contrast agents to generate high-resolution images of biological structures. Organic small molecule contrast agents, in particular, are well suited for biomedical imaging applications due to their favorable biocompatibility and amenability to structural modification. PET/SPECT, MRI, and fluorescence imaging all have a large host of small molecule contrast agents developed for them, and there exists an academic understanding of how these compounds can be developed. Optoacoustic imaging is a relatively newer imaging technique and, as such, lacks well-established small molecule contrast agents; many of the contrast agents used are the same ones which have found use in fluorescence imaging applications. Many commonly-used fluorescent dyes have found successful application in optoacoustic imaging, but others generate no detectable signal. Moreover, the structural features that either enable a molecule to generate a detectable optoacoustic signal or prevent it from doing so are poorly understood, so design of new contrast agents lacks direction. This review aims to compile the small molecule optoacoustic contrast agents that have been successfully employed in the literature to bridge the information gap between molecular design and optoacoustic signal generation. The information contained within will help to provide direction for the future synthesis of optoacoustic contrast agents.
Keywords: contrast agents; near-infrared; optoacoustic; small molecule.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
















Similar articles
-
Multimodal Contrast Agents for Optoacoustic Brain Imaging in Small Animals.Front Bioeng Biotechnol. 2021 Sep 28;9:746815. doi: 10.3389/fbioe.2021.746815. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34650961 Free PMC article. Review.
-
Emerging contrast agents for multispectral optoacoustic imaging and their biomedical applications.Chem Soc Rev. 2021 Jul 21;50(14):7924-7940. doi: 10.1039/d1cs00358e. Epub 2021 Jun 11. Chem Soc Rev. 2021. PMID: 34114588 Review.
-
Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications.Int J Mol Sci. 2017 Aug 7;18(8):1719. doi: 10.3390/ijms18081719. Int J Mol Sci. 2017. PMID: 28783106 Free PMC article. Review.
-
Sonophore-enhanced nanoemulsions for optoacoustic imaging of cancer.Chem Sci. 2018 May 18;9(25):5646-5657. doi: 10.1039/c8sc01706a. eCollection 2018 Jul 7. Chem Sci. 2018. PMID: 30061998 Free PMC article.
-
Comparison of the optoacoustic signal generation efficiency of different nanoparticular contrast agents.Appl Opt. 2012 Nov 20;51(33):8041-6. doi: 10.1364/AO.51.008041. Appl Opt. 2012. PMID: 23207315
Cited by
-
Photoacoustic Properties of Polypyrrole Nanoparticles.Nanomaterials (Basel). 2021 Sep 21;11(9):2457. doi: 10.3390/nano11092457. Nanomaterials (Basel). 2021. PMID: 34578773 Free PMC article.
-
Multi-Aspect Optoacoustic Imaging of Breast Tumors under Chemotherapy with Exogenous and Endogenous Contrasts: Focus on Apoptosis and Hypoxia.Biomedicines. 2021 Nov 16;9(11):1696. doi: 10.3390/biomedicines9111696. Biomedicines. 2021. PMID: 34829925 Free PMC article.
-
A Facile Approach to Producing Liposomal J-Aggregates of Indocyanine Green with Diagnostic and Therapeutic Potential.Adv Ther (Weinh). 2024 Aug;7(8):2400042. doi: 10.1002/adtp.202400042. Epub 2024 Jul 12. Adv Ther (Weinh). 2024. PMID: 39132131 Free PMC article.
-
Advances in photoacoustic imaging aided by nano contrast agents: special focus on role of lymphatic system imaging for cancer theranostics.J Nanobiotechnology. 2023 Nov 20;21(1):437. doi: 10.1186/s12951-023-02192-8. J Nanobiotechnology. 2023. PMID: 37986071 Free PMC article. Review.
-
Design Principles Governing the Development of Theranostic Anticancer Agents and Their Nanoformulations with Photoacoustic Properties.Pharmaceutics. 2022 Feb 4;14(2):362. doi: 10.3390/pharmaceutics14020362. Pharmaceutics. 2022. PMID: 35214094 Free PMC article. Review.
References
-
- Ntziachristos V., Schellenberger E.A., Ripoll J., Yessayan D., Graves E., Bogdanov A., Josephson L., Weissleder R. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc. Natl. Acad. Sci. USA. 2004;101:12294–12299. doi: 10.1073/pnas.0401137101. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous